Department of Chemistry, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.
Proteins. 2024 Aug;92(8):959-974. doi: 10.1002/prot.26692. Epub 2024 Apr 11.
Peptides are promising therapeutic agents for various biological targets due to their high efficacy and low toxicity, and the design of peptide ligands with high binding affinity to the target of interest is of utmost importance in peptide-based drug design. Introducing a conformational constraint to a flexible peptide ligand using a side-chain lactam-bridge is a convenient and efficient method to improve its binding affinity to the target. However, in general, such a small structural modification to a flexible ligand made with the intent of lowering the configurational entropic penalty for binding may have unintended consequences in different components of the binding enthalpy and entropy, including the configurational entropy component, which are still not clearly understood. Toward probing this, we examine different components of the binding enthalpy and entropy as well as the underlying structure and dynamics, for a side-chain lactam-bridged peptide inhibitor and its flexible analog forming complexes with vascular endothelial growth factor (VEGF), using all-atom molecular dynamics simulations. It is found that introducing a side-chain lactam-bridge constraint into the flexible peptide analog led to a gain in configurational entropy change but losses in solvation entropy, solute internal energy, and solvation energy changes upon binding, pinpointing the opportunities and challenges in drug design. The present study features an interplay between configurational and solvation entropy changes, as well as the one between binding enthalpy and entropy, in ligand-target binding upon imposing a conformational constraint into a flexible ligand.
肽由于其高效低毒的特点,是各种生物靶点有前途的治疗剂,设计与靶标具有高结合亲和力的肽配体是基于肽的药物设计中最重要的。在肽配体中引入侧链内酰胺桥以形成构象约束是提高其与靶标结合亲和力的一种方便有效的方法。然而,通常情况下,这种对具有降低结合构象熵罚目的的柔性配体的微小结构修饰可能会对结合焓和熵的不同组成部分产生意想不到的后果,包括构象熵组成部分,这些部分仍未得到清楚的理解。为了探究这一点,我们使用全原子分子动力学模拟,研究了侧链内酰胺桥肽抑制剂及其与血管内皮生长因子(VEGF)形成复合物的柔性类似物的结合焓和熵的不同组成部分以及潜在的结构和动力学。结果发现,在柔性肽类似物中引入侧链内酰胺桥约束导致构象熵变化增加,但结合时溶剂化熵、溶质内能和溶剂化能变化减少,这指明了药物设计中的机遇和挑战。本研究的特点是在将构象约束施加到柔性配体上时,构象熵和溶剂化熵变化之间以及结合焓和熵之间的相互作用。